Chen Ding
chend@fudan.edu.cn
Chinese, English
Shanghai
Fudan University
Life Sciences
  • 2008 - Ph.D. in Cell Biology: University of Science and Technology of China
  • Postdoctoral Research: Baylor College of Medicine, USA
  • PI at State Key Laboratory of Genetic Engineering, Fudan University
  • Professor at Zhongshan Hospital, Fudan University
  • Secretary General of the Phenome Society of the Chinese Biophysical Society
  • Founding Executive Editor of 'Phenomics' journal
  • Chief Scientist of the National Key R&D Program 'Biomacromolecules and Microorganisms'
  • Selected for National High-Level Talent Special Program
  • Selected for National Overseas High-Level Talent Program
  • Beijing 'Haihe Project'
  • Beijing 'Outstanding Young Talent'
  • Shanghai 'Morning Star Talent'
  • Shanghai 'Outstanding Discipline Leader'
  • 2012-2015 - Beijing Proteome Research Center - Associate Researcher, Researcher
  • 2015-Present - Fudan University - Professor, PI at State Key Laboratory of Genetic Engineering
  • 2013 - Beijing 'Haihe Project'
  • 2014 - Beijing 'Outstanding Young Talent'
  • 2019 - Shanghai 'Morning Star Talent'
  • 2022 - Shanghai 'Outstanding Discipline Leader'
Proteomics-based transcriptional regulation analysis
  • Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma, Tong, Y., Sun, M., Chen, L., Wang, Y., Li, Y., Li, L., . . . Ding, C., 2022
  • Integrated proteogenomic characterization of urothelial carcinoma of the bladder, Xu, N., Yao, Z., Shang, G., Ye, D., Wang, H., Zhang, H., . . . Ding, C., 2022
  • Integrated proteomic and transcriptomic landscape of macrophages in mouse tissues, Qie, J., Liu, Y., Wang, Y., Zhang, F., Qin, Z., Tian, S., . . . Ding, C., 2022
  • Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals new therapeutic strategies, Li, Y., Xu, C., Wang, B., Xu, F., Ma, F., Qu, Y., . . . Ding, C., 2022
  • Proteogenomic characterization of cholangiocarcinoma, Deng, M., Ran, P., Chen, L., Wang, Y., Yu, Z., Cai, K., . . . Ding, C., 2022
  • A proteogenomic analysis of clear cell renal cell carcinoma in a Chinese population, Qu, Y., Feng, J., Wu, X., Bai, L., Xu, W., Zhu, L., . . . Ding, C., 2022
  • Proteogenomic characterization of MiT family translocation renal cell carcinoma, Qu, Y., Wu, X., Anwaier, A., Feng, J., Xu, W., Pei, X., . . . Ding, C., 2022
  • Proteome-wide profiling of transcriptional machinery on accessible chromatin with biotinylated transposons, Zhang, H., Qin, Z., Yue, X., Liu, Y., Sun, X., Feng, J., . . . Ding, C., 2021
  • Proteome-Wide Profiling of Readers for DNA Modification, Bai, L., Yang, G., Qin, Z., Lyu, J., Wang, Y., Feng, J., . . . Ding, C., 2021
  • A proteomics landscape of circadian clock in mouse liver, Wang, Y., Song, L., Liu, M., Ge, R., Zhou, Q., Liu, W., . . . Ding, C., 2018
  • Firmiana: towards a one-stop proteomic cloud platform for data processing and analysis, Feng, J., Ding, C., Qiu, N., Ni, X., Zhan, D., Liu, W., . . . Qin, J., 2017
Proteomics Transcriptional Regulation Cloud Platform Firmiana Cattfre Modi-Tfre Atac-Ms Glioma Gastric Cancer Liver Cancer

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.